Atıf Formatları
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. P. Marso Et Al. , "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes," NEW ENGLAND JOURNAL OF MEDICINE , vol.375, no.4, pp.311-322, 2016

Marso, S. P. Et Al. 2016. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE , vol.375, no.4 , 311-322.

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., ... Nissen, S. E.(2016). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE , vol.375, no.4, 311-322.

Marso, Steven Et Al. "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes," NEW ENGLAND JOURNAL OF MEDICINE , vol.375, no.4, 311-322, 2016

Marso, Steven P. Et Al. "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes." NEW ENGLAND JOURNAL OF MEDICINE , vol.375, no.4, pp.311-322, 2016

Marso, S. P. Et Al. (2016) . "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes." NEW ENGLAND JOURNAL OF MEDICINE , vol.375, no.4, pp.311-322.

@article{article, author={Steven P. Marso Et Al. }, title={Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2016, pages={311-322} }